GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...

Tirzepatide has been shown to be effective in OSA, but evidence related to comorbid insomnia and sleep apnea (COMISA) is lacking.

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

Viking Therapeutics (VKTX 5.71%) fell a whopping 39.2% from their previous close on Tuesday, Aug. 19. Investors were reacting ...

There is a low but increased risk of optic nerve disorders in patients with type 2 diabetes prescribed semaglutide or ...

Tirzepatide may be the most effective medication for weight loss, as it can provide a 15% to 20% reduction in body weight, compared to 10% to 15 % with semaglutide and 5% to 10% with liraglutide ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

The singer revealed in March that, along with working with a dietician and trainer, she started weight loss GLP-1 medication, ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...

The NHS will prescribe the weight-loss jab Mounjaro to more people in response to a dramatic price increase for private ...